CUTISS’ CEO, Dr Daniela Marino, explains the challenges facing bioengineering during the pandemic and how the company cope during a time of global uncertainty.
Skin...
CUTISS’ CEO Dr Daniela Marino explains the current challenges and opportunities in regenerative therapy for burn victims and patients with skin defects.
Skin is the...
CUTISS’ CEO Dr Daniela Marino discusses the current challenges and opportunities in regenerative therapy.
Skin is the largest organ in the human body, composed mainly...
Innovation News Network speaks to CUTISS’ CEO, Dr Daniela Marino about their plans for the next financing round for automated tissue therapies.
Skin is the...
More than 50 million people suffer from skin defects every year in the world, and require surgical intervention to restore skin function and appearance.
The...